KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Assets (2016 - 2025)

Gsk (GSK) has 4 years of Current Assets data on record, last reported at $25.2 billion in Q4 2021.

  • For Q4 2021, Current Assets changed N/A year-over-year to $25.2 billion; the TTM value through Dec 2021 reached $25.2 billion, changed N/A, while the annual FY2021 figure was $25.7 billion, N/A changed from the prior year.
  • Current Assets reached $25.2 billion in Q4 2021 per GSK's latest filing, down from $30.4 billion in the prior quarter.
  • Across five years, Current Assets topped out at $30.4 billion in Q4 2018 and bottomed at $21.1 billion in Q4 2017.
  • Average Current Assets over 3 years is $25.6 billion, with a median of $25.2 billion recorded in 2021.
  • Peak YoY movement for Current Assets: grew 1.65% in 2017, then skyrocketed 44.04% in 2018.
  • A 3-year view of Current Assets shows it stood at $21.1 billion in 2017, then skyrocketed by 44.04% to $30.4 billion in 2018, then fell by 17.25% to $25.2 billion in 2021.
  • Per Business Quant database, its latest 3 readings for Current Assets were $25.2 billion in Q4 2021, $30.4 billion in Q4 2018, and $21.1 billion in Q4 2017.